EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know

Arthur N Westover, Jennifer Perez, Zena Patel, Manish K Jha

Focus · 2026-04 · 24 (2) · 159-167

DOI: 10.1176/appi.focus.20250044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Focus, 2026-04. Verfasst von Arthur N Westover und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AntipsychoticsPharmacotherapyTardive DyskinesiaVesicular Monoamine Transporter 2 Inhibitorsdeutetrabenazinevalbenazine

Autor:innen und Institutionen

  • Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.
  • Center for Depression Research and Clinical Care, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas.
  • Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center, Dallas.

Zitieren

APA

Westover, A. N., Perez, J., Patel, Z., & Jha, M. K. (2026). VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know. Focus, 24(2), 159-167. https://doi.org/10.1176/appi.focus.20250044

Vancouver

Westover AN, Perez J, Patel Z, Jha MK. VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know. Focus. 2026;24(2):159-167. doi:10.1176/appi.focus.20250044

BibTeX
@article{Westover2026,
  author = {Westover, Arthur N and Perez, Jennifer and Patel, Zena and Jha, Manish K},
  title = {VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know},
  journal = {Focus},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {159--167},
  doi = {10.1176/appi.focus.20250044}
}
Kostenlos starten →